144 related articles for article (PubMed ID: 33857339)
21. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
Morois S; Fournier A; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC
Eur J Epidemiol; 2012 Jun; 27(6):439-52. PubMed ID: 22644109
[TBL] [Abstract][Full Text] [Related]
23. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract][Full Text] [Related]
24. Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study.
Heuch I; Heuch I; Hagen K; Storheim K; Zwart JA
BMC Musculoskelet Disord; 2023 Jan; 24(1):84. PubMed ID: 36721124
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk.
Tian Y; Kim AE; Bien SA; Lin Y; Qu C; Harrison TA; Carreras-Torres R; Díez-Obrero V; Dimou N; Drew DA; Hidaka A; Huyghe JR; Jordahl KM; Morrison J; Murphy N; Obón-Santacana M; Ulrich CM; Ose J; Peoples AR; Ruiz-Narvaez EA; Shcherbina A; Stern MC; Su YR; van Duijnhoven FJB; Arndt V; Baurley JW; Berndt SI; Bishop DT; Brenner H; Buchanan DD; Chan AT; Figueiredo JC; Gallinger S; Gruber SB; Harlid S; Hoffmeister M; Jenkins MA; Joshi AD; Keku TO; Larsson SC; Le Marchand L; Li L; Giles GG; Milne RL; Nan H; Nassir R; Ogino S; Budiarto A; Platz EA; Potter JD; Prentice RL; Rennert G; Sakoda LC; Schoen RE; Slattery ML; Thibodeau SN; Van Guelpen B; Visvanathan K; White E; Wolk A; Woods MO; Wu AH; Campbell PT; Casey G; Conti DV; Gunter MJ; Kundaje A; Lewinger JP; Moreno V; Newcomb PA; Pardamean B; Thomas DC; Tsilidis KK; Peters U; Gauderman WJ; Hsu L; Chang-Claude J
J Natl Cancer Inst; 2022 Aug; 114(8):1135-1148. PubMed ID: 35512400
[TBL] [Abstract][Full Text] [Related]
26. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
[TBL] [Abstract][Full Text] [Related]
27. Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study.
Velentzis LS; Egger S; Banks E; Canfell K
PLoS One; 2021; 16(8):e0253725. PubMed ID: 34379634
[TBL] [Abstract][Full Text] [Related]
28. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
[TBL] [Abstract][Full Text] [Related]
29. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
Tian Y; Lin Y; Qu C; Arndt V; Baurley JW; Berndt SI; Bien SA; Bishop DT; Brenner H; Buchanan DD; Budiarto A; Campbell PT; Carreras-Torres R; Casey G; Chan AT; Chen R; Chen X; Conti DV; Díez-Obrero V; Dimou N; Drew DA; Figueiredo JC; Gallinger S; Giles GG; Gruber SB; Gunter MJ; Harlid S; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Joshi AD; Keku TO; Kawaguchi E; Kim AE; Kundaje A; Larsson SC; Marchand LL; Lewinger JP; Li L; Moreno V; Morrison J; Murphy N; Nan H; Nassir R; Newcomb PA; Obón-Santacana M; Ogino S; Ose J; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Potter JD; Prentice RL; Rennert G; Ruiz-Narvaez EA; Sakoda LC; Schoen RE; Shcherbina A; Stern MC; Su YR; Thibodeau SN; Thomas DC; Tsilidis KK; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; White E; Wolk A; Woods MO; Wu AH; Peters U; Gauderman WJ; Hsu L; Chang-Claude J
Br J Cancer; 2024 Jun; 130(10):1687-1696. PubMed ID: 38561434
[TBL] [Abstract][Full Text] [Related]
30. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
31. Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.
Cote DJ; Kilgallon JL; Nawabi NLA; Dawood HY; Smith TR; Kaiser UB; Laws ER; Manson JE; Stampfer MJ
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1402-e1412. PubMed ID: 34865056
[TBL] [Abstract][Full Text] [Related]
32. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
[TBL] [Abstract][Full Text] [Related]
33. Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
Fournier A; Cairat M; Severi G; Gunter MJ; Rinaldi S; Dossus L
J Natl Cancer Inst; 2023 Jun; 115(6):671-679. PubMed ID: 36809347
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
[TBL] [Abstract][Full Text] [Related]
35. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
36. Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.
Felix AS; Arem H; Trabert B; Gierach GL; Park Y; Pfeiffer RM; Brinton LA
Cancer Causes Control; 2015 Aug; 26(8):1055-63. PubMed ID: 25962764
[TBL] [Abstract][Full Text] [Related]
37. Menopausal hormone therapy and risk of colorectal cancer.
Johnson JR; Lacey JV; Lazovich D; Geller MA; Schairer C; Schatzkin A; Flood A
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):196-203. PubMed ID: 19124498
[TBL] [Abstract][Full Text] [Related]
38. Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women.
Tillmans LS; Vierkant RA; Wang AH; Samadder NJ; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):713-9. PubMed ID: 25650184
[TBL] [Abstract][Full Text] [Related]
39. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
Yuk JS; Jeong SH
J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
[TBL] [Abstract][Full Text] [Related]
40. Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review.
Tempfer CB; Hilal Z; Kern P; Juhasz-Boess I; Rezniczek GA
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
